“How Do We Actually Do Convergence” for Disaster Resilience?Cases from Australia and the United Stat

来源 :国际灾害风险科学学报(英文版) | 被引量 : 0次 | 上传用户:yunkan
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
In recent years there has been an increasing emphasis on achieving convergence in disaster research,policy,and programs to reduce disaster losses and enhance social well-being.However,there remain considerable gaps in understanding “how do we actually do conver-gence?” In this article,we present three case studies from across geographies—New South Wales in Australia,and North Carolina and Oregon in the United States;and sec-tors of work community,environmental,and urban resi-lience,to critically examine what convergence entails and how it can enable diverse disciplines,people,and institu-tions to reduce vulnerability to systemic risks in the twenty-first century.We identify key successes,challenges,and barriers to convergence.We build on current discus-sions around the need for convergence research to be problem-focused and solutions-based,by also considering the need to approach convergence as ethic,method,and outcome.We reflect on how convergence can be approa-ched as an ethic that motivates a higher order alignment on“why” we come together;as a method that foregrounds“how” we come together in inclusive ways;and as an outcome that highlights “what” must be done to success-fully translate research findings into the policy and public domains.
其他文献
目的探讨肿痛安胶囊联合沙利度胺治疗复发性口腔溃疡的疗效及其对免疫细胞的影响。方法选取2019年5月-2020年12月绵阳市中心医院收治的92例复发性口腔溃疡患者作为研究对象,按照治疗方法将患者分为对照组和观察组,每组各46例。对照组口服沙利度胺片,50 mg/次,2次/d。观察组在对照组基础上口服肿痛安胶囊,0.56 g/次,3次/d。两组均连续治疗7 d。观察两组的临床疗效及临床症状改善时间,同时比较两组治疗前后的视觉模拟评分法(VAS)评分和免疫指标水平。结果治疗后,观察组患者的总有效率为93.48%
The COVID-19 pandemic has caused numerous deaths around the world.A growing body of evidence points to the important role of overwhelming inflammatory responses
The avian influenza A(H7N9)virus is a zoonotic virus that is closely associated with live poultry markets.It has caused infections in humans in China since 2013
目的制备三黄地榆油微乳凝胶剂,并评价其对大鼠深Ⅱ度烫伤创面愈合作用的治疗效果。方法通过评估三黄地榆油在油相、乳化剂和助乳化剂中的溶解性能及相容性,确定了三黄地榆油自乳化释药系统的处方组成,并采用伪三元相图法获得其处方用量;在透射电镜下观察了三黄地榆油微乳的微观结构,通过马尔文激光粒度仪测定了微乳的粒径分布及Zeta电位;并以卡波姆940作为凝胶基质将三黄地榆油微乳制备成凝胶剂;建立大鼠深Ⅱ度烫伤模型,比较空白微乳凝胶、三黄地榆油微乳凝胶(1 g,含三黄地榆油13 mg)、三黄地榆油(13 mg)和京万红烫
This year marks the 10-year anniversary of the Interna-tional Journal of Disaster Risk Science (IJDRS).On this occasion,as Editors-in-Chief,we are deeply gratef
期刊
Expert scientific knowledge is fast becoming an integral part of disaster management,and,in the process,is changing the role of science for the reduction of dis
Spinal disease is an important cause of cervical discomfort,low back pain,radiating pain in the limbs,and neurogenic intermittent claudication,and its incidence
Stevens-Johnson syndrome(SJS)and toxic epidermal necrolysis(TEN)are rare but severe diseases.This study aimed to validate the predictive ability of risk models
The protection of language function is one of the major challenges of brain surgery.Over the past century,neurosurgeons have attempted to seek the optimal strat
目的探讨阿帕替尼联合卡培他滨治疗胃癌患者的临床疗效及其对血清肿瘤标志物水平的影响。方法回顾性分析2016年11月-2020年11月中国科学院中关村医院收治的80例胃癌患者,根据治疗方法将患者分为对照组(41例)和观察组(39例)。对照组患者口服卡培他滨片,1000 mg/m2,2次/d,治疗2周后停药1周,21 d为1个周期。观察组在对照组的基础上口服甲磺酸阿帕替尼片,500 mg/次,1次/d,治疗2周,21 d为1个周期。患者需维持用药3个周期。观察两组患者的临床疗效,同时比较两